author-photo

Peter David Davis

Health and Safety Executive

15

Papers

504

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

The Novel Vascular Disrupting Agent ANG501 Induces Cell Cycle Arrest and Enhances Endothelial Cell Sensitivity to Radiation

2009
Show All
- Source
- Cite
- Save
Citations (2)
Hypoxia-driven elimination of thiopurines from their nitrobenzyl prodrugs.

2007 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (13)
Development of Vasculature‐targeted Cancer Gene Therapy

2006
Show All
- Source
- Cite
- Save
Citations (0)
Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4

2006 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (29)
Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression

2004 Cancer Gene Therapy
Show All
- Source
- Cite
- Save
Citations (10)
497 A bioreductive prodrug of combretstatin A4

2004 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (0)
Vascular-targeted cancer gene therapy.

2004 Expert Opinion on Biological Therapy
Show All
- Source
- Cite
- Save
Citations (3)
Prodrogues activées par bioréduction

2004
Show All
- Source
- Cite
- Save
Citations (0)
Enhancement of vascular targeting by inhibitors of nitric oxide synthase

2002 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (17)
ZD6126 A Novel Vascular-targeting Agent That Causes Selective Destruction of Tumor Vasculature

2002 Cancer Research
Show All
- Source
- Cite
- Save
Citations (225)